Global Self-injection Devices Market Size study & Forecast, by Product (Autoinjectors, Pen Injectors, Wearable Injectors, Needle-free Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders, Pain M

Global Self-injection Devices Market Size study & Forecast, by Product (Autoinjectors, Pen Injectors, Wearable Injectors, Needle-free Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, Others) and Regional Analysis, 2023-2030

Global Self-injection Devices Market is valued at approximately USD 6.98 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2023-2030. Self-injection devices, also known as autoinjectors or self-injectors, are medical devices designed to allow individuals to administer medications to themselves through a subcutaneous under the skin or into the muscle route. These devices are commonly used for the self-administration of medications such as insulin, epinephrine, and certain other injectable medications for the treatment of various medical conditions, including diabetes, severe allergic reactions, and autoimmune diseases. The Self-injection Devices market is expanding because of factors such as rising diabetes prevalence and growing geriatric Population.

According to the World Health Organization, diabetes will afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, as per Statista, diabetes affected around 10.5% of the global adult population in 2021; by 2045, this figure is predicted to climb to more than 12%. Since diabetes is a self-examined disease as it needs personal assistance and can be controlled by regular medical surveillance. Another important component driving space is growing geriatric population. According to the World Bank Group, the global elderly population was 727 million in 2020, and it is expected to triple in the next three decades, reaching 1.5 billion by 2050. In addition, by 2050, 80% of older people will be living in low- and middle-income countries. The pace of population ageing is much faster than in the past. Also, rising technological advancements in self-injection devices and increasing government regulatory approvals would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Self-injection Devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Self-injection Devices Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players. According to Statista, the medical devices industry in the United States was valued at 226 billion US dollars in 2021 and is expected to reach 312 billion US dollars by 2027, with an annual growth rate of 5.38 % during this time period. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric populations, and active participation of government organizations in the market space.

Major market players included in this report are:
Ypsomed AG
Becton, Dickinson and Company.
Gerresheimer AG
Antares Pharma
Haselmeier AG
NuGen Medical Devices
Owen Mumford Ltd
SHL Medical AG
Pfizer, Inc.
Amgen Inc

Recent Developments in the Market:
In April 2023, BD a leading worldwide medical technology firm, launched a new, ultrasound device with a specialized probe designed to help physicians put IVs correctly.

Global Self-injection Devices Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Usability, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product
Autoinjectors
Pen Injectors
Wearable Injectors
Needle-free Injectors

By Usability
Disposable
Reusable

By Application
Cancer
Autoimmune Disorders
Hormonal Disorders
Pain Management
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Ypsomed AG
Becton, Dickinson and Company.
Gerresheimer AG
Antares Pharma
Haselmeier AG
NuGen Medical Devices
Owen Mumford Ltd
SHL Medical AG
Pfizer, Inc.
Amgen Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.